mascot registry (OrbusNeich)
90
Structured Review
OrbusNeich
mascot registry
Mascot Registry, supplied by OrbusNeich, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mascot+registry/mascot+registry/pm33515411-122-10-0
Average 90 stars, based on 1 article reviews
Mascot Registry, supplied by OrbusNeich, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mascot+registry/mascot+registry/pm33515411-122-10-0
Average 90 stars, based on 1 article reviews
mascot registry - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration. Article Snippet: Jaya Chandrasekhar MBBS, MS | Laura S. Kerkmeijer MD | Deborah N. Kalkman MD, PhD | Samantha Sartori PhD | Melissa B. Aquino MS | Pier Woudstra MD, PhD | Marcel A. Beijk MD, PhD | Jan G. Tijssen PhD | Karel T. Koch MD, PhD | Petr Hájek MD, PhD | Borislav Atzev MD, PhD | Martin Hudec MD | Tiong K. Ong MD | Martin Mates MD | Borislav Borisov MD | Hazem M. Warda MD | Peter den Heijer MD, PhD | Jaroslaw Wojcik MD | Andres Iñiguez MD, PhD | Zdeněk Coufal MD | Ahmed Khashaba MD | Muhammad Munawar MD | Robert T. Gerber MD | Bryan P. Yan MD | Michael Lee MD | Usman Baber MD, MS | George D. Dangas MD, PhD | Antonio Colombo MD | Robbert J. de Winter MD, PhD | Roxana Mehran MD | On behalf of the MASCOT and REMEDEE investigators (full list of collaborators shown in the Appendix) Article Title: 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. Article Snippet: Article Title: Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry). Article Snippet: Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry) Jaya Chandrasekhar, MBBS, MS, Samantha Sartori, PhD, Melissa B. Aquino, MS, Usman Baber, MD MS, Petr H ajek, MD, PhD, Borislav Atzev, MD, PhD, Martin Hudec, MD, Tiong Kiam Ong, MD, Martin Mates, MD, Borislav Borisov, MD, Hazem M. Warda, MD, Peter den Heijer, MD, PhD, Jaroslaw Wojcik, MD, Andres Iniguez, MD, PhD, Zden ek Coufal, MD, Ahmed Khashaba, MD, Alexandr Schee, MD, Muhammad Munawar, MD, Robert T. Gerber, MD, Bryan P. Yan, MD, Paula Tejedor, MD, Petr Kala, MD, Houng Bang Liew, MD, Michael Lee, MD, Deborah N. Kalkman, MD, PhD, George D. Dangas, MD, PhD, Robbert J. de Winter, MD, PhD, Antonio Colombo, MD, and Roxana Mehran, MD*, On behalf of the MASCOT investigators (Appendix I) Article Title: One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration. Article Snippet: Purpose The COMBO biodegradable polymer sirolimus-eluting stent includes endothelial progenitor cell capture (EPC) technology for rapid endothelialization, which may offer advantage in acute coronary syndromes (ACS).. We sought to analyze the performance of the COMBO stent by ACS status and ACS subtype.. Methods The COMBO collaboration (n= 3614) is a patient-level pooled dataset from the MASCOT and REMEDEE registries. Article Title: 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry Article Snippet: 10.13039/100011408 |